Exact Mass: 402.2254
Exact Mass Matches: 402.2254
Found 500 metabolites which its exact mass value is equals to given mass value 402.2254
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gamabufogenin
Gamabufogenin is a steroid lactone. It is functionally related to a bufanolide. Gamabufotalin is a natural product found in Bufotes viridis, Bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways. Gamabufotalin (Gamabufagin), a main active compound isolated from Chinese medicine Chansu, has been shown to strongly inhibit cancer cell growth and inflammatory response. Gamabufotalin could inhibite angiogenesis by inhibiting the activation of VEGFR-2 signaling pathways.
Telobufotoxin
Telocinobufagin is a steroid lactone. It is functionally related to a bufanolide. Telocinobufagin is a natural product found in Bufo gargarizans, Bufo bufo, and other organisms with data available. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis. Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis.
ST 24:4;O5
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D01693
Trandolaprilat
Trandolaprilat is a metabolite of trandolapril. Trandolapril is an ACE inhibitor used to treat high blood pressure, it may also be used to treat other conditions. It is marketed by Abbott Laboratories with the brand name Mavik. (Wikipedia) C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
Lucidone A
Lucidone A is found in mushrooms. Lucidone A is a constituent of Ganoderma lucidum (reishi)
Cinitapride
Cinitapride is only found in individuals that have used or taken this drug.Cinitapride is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in Spain and Mexico. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cinitapride is a nonselective 5-HT1 and 5-HT4 receptors agonist and a 5-HT2 and D2 antagonist. Cinitapride can be used in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) research[1].
Acetyl tributyl citrate
Acetyl tributyl citrate is a flavouring ingredient and plasticiser used in packaging films for food. Flavouring ingredient. Plasticiser used in packaging films for food [DFC].
1-(2-((1-Carboxy-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indole-2-carboxylic acid
Gamabufotalin
Telocinobufagin
3-dehydrocholate
3-dehydrocholate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-dehydrocholate can be found in a number of food items such as kale, cucurbita (gourd), atlantic herring, and spearmint, which makes 3-dehydrocholate a potential biomarker for the consumption of these food products. Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load .
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
17-Succinoyloxy-ent-cleroda-3,13(16),14-trien-15,16-oxide
3alpha,14alpha-Diacetoxy-2beta-hydroxy-1(15),8(19),9-trinervitatriene
(S)-AL 8810
N-(1-amino-4-hydroxy-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide
3alpha,9,14-Trihydroxy-5beta,14beta-bufa-20,22-dienolid|3alpha,9,14-trihydroxy-5beta,14beta-bufa-20,22-dienolide
1beta,11alpha-Diacetoxy-7-oxosandaracopimar-8(14),15-dien
7beta-angeloyloxy-8alpha-isobutyryloxylongipin-2-en-1-one
2-oxo-18,19-diacetoxy-10alpha,17alpha,19alpha,20beta-(-)-cleroda-3,13(16),14-triene
24-methyl-25-oxo-hexacos-2,5,7,9,11,13,15,17,19,21,23-undecaenoic acid
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one|3beta,15beta-diacetoxylathyra-5E,12E-dien-14-one|jolkinoate A
(2E,4E,6E)-6-(1-carboxyocta-2,4,6-triene)-11,12-epoxy-9-hydroxy-11-methoxy-drim-7-ene
6-O-alpha-E-p-coumaroyl-1beta,4alpha-dihydroxyeudesmane
2alpha-isobutyryloxy-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
hexanocucurbitacin D|Hexanor-cucurbitacin D|Hexanorcucurbitacin D
(3beta,4beta,5beta,14beta)-3,4,14-Trihydroxybufa-20,22-dienolide
Di-Ac-7, 8-Epoxy-3, 12(18), 13-dolabellatriene-19, 20-diol
(1S,2R,3E,7E,11S,12R,13S)-2,13-diacetoxydolabella-3,7,18-trien-9-one
7alpha-hydroxy-8,11,13-abietatriene-18-succinic acid|abiesadine F
6alpha,12-diacetoxy-7beta-hydroxyabieta-8,11,13-triene|fortunin B
Hexanorcucurbitacin D
hexanorcucurbitacin D is a natural product found in Begonia parviflora, Cucumis melo, and other organisms with data available.
Dehydrocholic acid
Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. It acts as a hydrocholeretic, increasing bile output to clear increased bile acid load. 3,7,12-trioxo-5beta-cholanic acid is an oxo-5beta-cholanic acid in which three oxo substituents are located at positions 3, 7 and 12 on the cholanic acid skeleton. It has a role as a gastrointestinal drug. It is an oxo-5beta-cholanic acid, a 7-oxo steroid, a 12-oxo steroid and a 3-oxo-5beta-steroid. It is a conjugate acid of a 3,7,12-trioxo-5beta-cholan-24-oate. Dehydrocholic acid is a synthetic bile acid that was prepared from the oxidation of cholic acid with chromic acid. It has been used for stimulation of biliary lipid secretion. The use of dehydrocholic acid in over-the-counter products has been discontinued by Health Canada.
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
3,7,12-Trioxo-5b-cholan-24-oic acid
BA-119-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-119-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
3,7,12-Trioxo-5a-cholan-24-oic acid
BA-128-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-128-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Acetyl tributyl citrate
CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10214; ORIGINAL_PRECURSOR_SCAN_NO 10209 CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10264; ORIGINAL_PRECURSOR_SCAN_NO 10263 CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10273; ORIGINAL_PRECURSOR_SCAN_NO 10271 CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10322; ORIGINAL_PRECURSOR_SCAN_NO 10320 CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10328; ORIGINAL_PRECURSOR_SCAN_NO 10327 CONFIDENCE standard compound; INTERNAL_ID 523; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10342; ORIGINAL_PRECURSOR_SCAN_NO 10341
Ala Ala Glu Ile
Ala Ala Glu Leu
Ala Ala Ile Glu
Ala Ala Lys Asn
Ala Ala Leu Glu
Ala Ala Asn Lys
Ala Asp Val Val
Ala Glu Ala Ile
Ala Glu Ala Leu
Ala Glu Ile Ala
Ala Glu Leu Ala
Ala Gly Lys Gln
Ala Gly Gln Lys
Ala Ile Ala Glu
Ala Ile Glu Ala
Ala Lys Ala Asn
Ala Lys Gly Gln
Ala Lys Asn Ala
Ala Lys Gln Gly
Ala Leu Ala Glu
Ala Leu Glu Ala
Ala Asn Ala Lys
Ala Asn Lys Ala
Pregn-4-ene-3,20-dione, 6a,17-dihydroxy-6-methyl-, 17-acetate
Pregn-4-ene-3,20-dione, 6b,17-dihydroxy-6-methyl-, 17-acetate
Ala Gln Gly Lys
7,21-Dihydroxy-6a-methylpregn-4-ene-3,20-dione 17-acetate
Ala Gln Lys Gly
Ala Val Asp Val
Ala Val Val Asp
Asp Ala Val Val
Asp Gly Ile Val
Asp Gly Leu Val
Asp Gly Val Ile
Asp Gly Val Leu
Asp Ile Gly Val
Asp Ile Val Gly
Asp Leu Gly Val
Asp Leu Val Gly
Asp Val Ala Val
Asp Val Gly Ile
Asp Val Gly Leu
Asp Val Ile Gly
Asp Val Leu Gly
Asp Val Val Ala
Glu Ala Ala Ile
Glu Ala Ala Leu
Glu Ala Ile Ala
Glu Ala Leu Ala
Glu Gly Val Val
Glu Ile Ala Ala
Glu Leu Ala Ala
Glu Val Gly Val
Glu Val Val Gly
Gly Ala Lys Gln
Gly Ala Gln Lys
Gly Asp Ile Val
Gly Asp Leu Val
Gly Asp Val Ile
Gly Asp Val Leu
Gly Glu Val Val
Gly Ile Asp Val
Gly Ile Val Asp
Gly Lys Ala Gln
Gly Lys Gln Ala
Gly Leu Asp Val
Gly Leu Val Asp
Gly Gln Ala Lys
Gly Gln Lys Ala
Gly Val Asp Ile
Gly Val Asp Leu
Gly Val Glu Val
Gly Val Ile Asp
Gly Val Leu Asp
Gly Val Val Glu
Ile Ala Ala Glu
Ile Ala Glu Ala
Ile Asp Gly Val
Ile Asp Val Gly
Ile Glu Ala Ala
Ile Gly Asp Val
Ile Gly Val Asp
Ile Pro Ser Ser
Ile Ser Pro Ser
Ile Ser Ser Pro
Ile Val Asp Gly
Ile Val Gly Asp
Lys Ala Ala Asn
Lys Ala Gly Gln
Lys Ala Asn Ala
Lys Ala Gln Gly
Lys Gly Ala Gln
Lys Gly Gln Ala
Lys Asn Ala Ala
Lys Gln Ala Gly
Lys Gln Gly Ala
Leu Ala Ala Glu
Leu Ala Glu Ala
Leu Asp Gly Val
Leu Asp Val Gly
Leu Glu Ala Ala
Leu Gly Asp Val
Leu Gly Val Asp
Leu Pro Ser Ser
Leu Ser Pro Ser
Leu Ser Ser Pro
Leu Val Asp Gly
Leu Val Gly Asp
Asn Ala Ala Lys
Asn Ala Lys Ala
Asn Lys Ala Ala
Pro Ile Ser Ser
Pro Leu Ser Ser
Pro Ser Ile Ser
Pro Ser Leu Ser
Pro Ser Ser Ile
Pro Ser Ser Leu
Pro Ser Thr Val
Pro Ser Val Thr
Pro Thr Ser Val
Pro Thr Val Ser
Pro Val Ser Thr
Pro Val Thr Ser
Gln Ala Gly Lys
Gln Ala Lys Gly
Gln Gly Ala Lys
Gln Gly Lys Ala
Gln Lys Ala Gly
Gln Lys Gly Ala
Ser Ile Pro Ser
Ser Ile Ser Pro
Ser Leu Pro Ser
Ser Leu Ser Pro
Ser Pro Ile Ser
Ser Pro Leu Ser
Ser Pro Ser Ile
Ser Pro Ser Leu
Ser Pro Thr Val
Ser Pro Val Thr
Ser Ser Ile Pro
Ser Ser Leu Pro
Ser Ser Pro Ile
Ser Ser Pro Leu
Ser Thr Pro Val
Ser Thr Val Pro
Ser Val Pro Thr
Ser Val Thr Pro
Thr Pro Ser Val
Thr Pro Val Ser
Thr Ser Pro Val
Thr Ser Val Pro
Thr Val Pro Ser
Thr Val Ser Pro
Val Ala Asp Val
Val Ala Val Asp
Val Asp Ala Val
Val Asp Gly Ile
Val Asp Gly Leu
Val Asp Ile Gly
Val Asp Leu Gly
Val Asp Val Ala
Val Glu Gly Val
Val Glu Val Gly
Val Gly Asp Ile
Val Gly Asp Leu
Val Gly Glu Val
Val Gly Ile Asp
Val Gly Leu Asp
Val Gly Val Glu
Val Ile Asp Gly
Val Ile Gly Asp
Val Leu Asp Gly
Val Leu Gly Asp
Val Pro Ser Thr
Val Pro Thr Ser
Val Ser Pro Thr
Val Ser Thr Pro
Val Thr Pro Ser
Val Thr Ser Pro
Val Val Ala Asp
Val Val Asp Ala
Val Val Glu Gly
Val Val Gly Glu
Trandolaprilat
A heterobicyclic compound that is trandolapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of the prodrug trandolapril. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
methyl ester
Cinitapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cinitapride is a nonselective 5-HT1 and 5-HT4 receptors agonist and a 5-HT2 and D2 antagonist. Cinitapride can be used in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) research[1].
lucidone A
[4-[[4-(diethylamino)-2-methylphenyl]azo]phenacyl]trimethylammonium chloride
(S)-tert-butyl 4-((R)-2-Methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-Methylpiperazine-1-carboxylate
17α-hydroxy-19-norpregna-5(10),9(11)-diene-3,20-dione 3,20-bis(ethylene acetal)
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid
4-[2-(2,6-Difluoro-4-pentylphenyl)ethynyl]-4-propyl-1,1-biphenyl
Acacia senegal, ext.
1H-Indol-2-carboxylic acid, 1-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)octahydro-
Spiroxasone
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal
(Z)-7-[(1R,2R,3S,5S)-2-[(E,3S)-3-(2,3-Dihydro-1H-inden-2-yl)-3-hydroxyprop-1-enyl]-3-fluoro-5-hydroxycyclopentyl]hept-5-enoic acid
Msh, beta, (6-8)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D009074 - Melanocyte-Stimulating Hormones
Morpholine-4-carboxylic acid [1S-(2-benzyloxy-1R-cyano-ethylcarbamoyl)-3-methyl-butyl]amide
Clascoterone
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
(3E,5E,7E,10R,12Z,14E,17R,18S,22S)-22-ethyl-10,18-dihydroxy-17-methyl-1-oxacyclodocosa-3,5,7,12,14-pentaene-2,16-dione
ambiguine I
An ambiguine that consists of a 5,5,7,10,10-pentamethyl-4,5,5a,6a,6b,7,8,9,9a,10-decahydro-10dH-6-oxa-4-azacyclopropa[6,7]cyclohepta[1,2,3,4-mno]aceanthrylen-10d-ol skeleton with an ethenyl substituent at position 7 and an isocyano group at position 6b (the 5aS,6aR,6bR,7R,9aR,10dR stereoisomer). An antimicrobial agent isolated from the cyanobacterium strain Fischerella.
(3E,5E,9E,11Z,17E,19E)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one
(Z)-7-[(1R,2R,3S,5S)-2-[(E,3R)-3-(2,3-dihydro-1H-inden-2-yl)-3-hydroxyprop-1-enyl]-3-fluoro-5-hydroxycyclopentyl]hept-5-enoic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists
(-)-(5E,12E,2S,3S,4S,9S,11S,15R)-3,15-diacetoxylathyra-5,12-dien-14-one
A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.
(4R)-4-[(10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
N-[6-amino-1-(2-methylpropyl)-2,4-dioxo-5-pyrimidinyl]-2-(2-methylphenoxy)-N-(2-methylpropyl)acetamide
(1R,2R,6R)-6-[(2E,6E,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3-methyl-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
4-[(5S,10S,13R,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
(1R,2S,6R)-3-methoxy-5-oxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
N-[(3-methoxyphenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]pyridine-3-carboxamide
N-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1S,2aS,8bS)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
1-[(3aR,4R,9bR)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(propylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1S,2aR,8bR)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aS,8bS)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aR,8bR)-1-(hydroxymethyl)-2-[2-(4-morpholinyl)-1-oxoethyl]-N-propyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(4R)-4-[(5S,8S,9R,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
Tributyl 2-carboxymethyl-1,2,3-propane tricarboxylate
7alpha,12alpha-Dihydroxy-3-oxochola-1,4-dien-24-oic Acid
yanuthone L
A class I yanuthone that is yanuthone K in which a hydrogen of the pro-E methyl group at the terminus of the farnesyl substituent has been replaced by a hydroxy group. Isolated from the filamentous fungus Aspergillus niger, it shows antifungal activity towards the pathogenic yeast Candida albicans (IC50 = 17.0 +-1.9 muM).
yanuthone X1
A class II yanuthone that is yanuthone X2 in which the hydroxy group at position 4 of the 5,6-epoxycyclohex-2-en-1-one core has been converted to the corresponding acetate ester. Like yanuthone X2, yanuthone X1 has been isolated from the filamentous fungus Aspergillus niger, but shows much lower antifungal activity towards the pathogenic yeast Candida albicans than yanuthone X2 (IC50 >100 muM for yanuthone X1, compared with = 51.7 +-4.7 muM for yanuthone X2).
19-Hydroxybufalin
19-Hydroxybufalin is a bufadienolide, inhibits epithelial-mesenchymal transition and attenuates the migration and invasion of PC3 cells[1].
(2s,3r,4s,5s,6r,7r,8r)-5,6,7-trihydroxy-2,4,6,8-tetramethyl-9-oxooxonan-3-yl (4r)-4-hydroxyoct-2-enoate
methyl (1s,2r,5r,10r,11r,13s,14s)-14-hydroxy-2,6,6,10,13-pentamethyl-16-methylidene-7,15-dioxotetracyclo[11.2.1.0²,¹¹.0⁵,¹⁰]hexadecane-1-carboxylate
(1e,10z,12e,15z,17e)-3,20,22-trihydroxy-7-methyl-3,4,5,6,7,14,18a,19,20,21,22,22a-dodecahydro-8-benzoxacycloicosin-9-one
(4bs,8as,9r,10r)-9-(acetyloxy)-10-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate
(1r,5r,7s,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
3-{5-[(2,5-dihydroxy-3-methylphenyl)methyl]-5,6,8a-trimethyl-2-oxo-hexahydro-1h-naphthalen-1-yl}propanoic acid
[(1r,2s,5s,9s,13r)-2-(acetyloxy)-5,9-dimethyl-14-methylidene-6-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
{5-[(acetyloxy)methyl]-1,2-dimethyl-1-(3-methylidenepent-4-en-1-yl)-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-4a-yl}methyl acetate
1-[(1s,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-4-methylpent-3-en-1-yl acetate
(3s)-2-[(1s,3r,4s,4as)-3-(acetyloxy)-4-methyl-7-methylidene-2,3,4,4a,5,6-hexahydro-1h-naphthalen-1-yl]-6-methyl-4-oxohept-5-en-3-yl acetate
[(3br,5as,6s,9as,9bs)-6-[(acetyloxy)methyl]-3b,6-dimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-9a-yl]methyl acetate
5-[(1r,3as,3br,5ar,7s,9ar,9bs,11ar)-3a,7-dihydroxy-9a-(hydroxymethyl)-11a-methyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one
(3r,3as,5r,8ar)-3a-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3,4,5,8-hexahydroazulen-5-yl 3,4-dimethoxybenzoate
(1s,5r,6s,8r)-8-{1-[(1r,3as,8as)-4,4,8a-trimethyl-8-methylidene-hexahydro-1h-azulen-1-yl]ethenyl}-3-oxo-2,7-dioxabicyclo[3.2.1]octan-6-yl acetate
3-(hydroxymethyl)-5-oxo-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
[5-(acetyloxy)-2-(2-methyl-5-oxocyclopent-3-en-1-yl)-3-(6-methylhepta-2,5-dien-2-yl)cyclopentyl]methyl acetate
(1r,2s,3as,4r,12as)-4-(acetyloxy)-3a,6,10-trimethyl-11-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,12h,12ah-cyclopenta[11]annulen-2-yl acetate
(4as,5r,6s,8ar)-3,4a-dimethyl-5-[(3-methylbutanoyl)oxy]-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2e)-2-methylbut-2-enoate
(2r)-1-(3-acetyl-4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,6-dihydroxy-5-methylphenyl)-2-methylbutan-1-one
(1e,3e,6e,10z)-3-[(acetyloxy)methylidene]-7-methyl-11-(4-methylpent-3-en-1-yl)-12-oxododeca-1,6,10-trien-1-yl acetate
(1r,2s,4s,5s,7r,8r)-3,3,7,9-tetramethyl-5-[(2-methylpropanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-4-yl (2z)-2-methylbut-2-enoate
(1s,3s,5r,7s,10s,14r,15s,17r,18s)-15-acetyl-7,17-dihydroxy-6,6,10,14,18-pentamethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-13-one
(2r)-2-[(2s,3r,4r)-3,4-dimethyl-5-oxo-3-(6,8,10-trimethyl-9-oxododeca-1,3,5,7-tetraen-1-yl)oxolan-2-yl]propanoic acid
[(1s,2r,3r,5r)-5-(acetyloxy)-2-[(1r,2r)-2-methyl-5-oxocyclopent-3-en-1-yl]-3-[(2z)-6-methylhepta-2,5-dien-2-yl]cyclopentyl]methyl acetate
[(3br,5ar,6s,7s,9ar,9br)-7-(acetyloxy)-3b,6,9a-trimethyl-4h,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-c]furan-6-yl]methyl acetate
(3r,3as,4s,8ar)-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3a,4,5,8-hexahydroazulen-4-yl 3,4-dimethoxybenzoate
methyl 4-hydroxy-3-{[1-(hydroxymethyl)-2,4a-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-methoxybenzoate
(1r,3e,5r,7s,10e,12s,13s,14s)-13-(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-1-yl acetate
4-{[(1s,2r,4ar,8ar)-1-[2-(furan-3-yl)ethyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methoxy}-4-oxobutanoic acid
1β-hydroxybufalin
{"Ingredient_id": "HBIN002411","Ingredient_name": "1\u03b2-hydroxybufalin","Alias": "NA","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CC12CCC3C(C1(CCC2C4=COC(=O)C=C4)O)CCC5C3(C(CC(C5)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9858","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene
{"Ingredient_id": "HBIN005123","Ingredient_name": "2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl)butyryl-benzene","Alias": "AC1NSTGW; 1-[3-Acetyl-2,6-dihydroxy-5-methyl-4-[(3,7-dimethyl-2,6-octadienyl)oxy]phenyl]-2-methyl-1-butanone; 1-[3-acetyl-4-[(2E)-3,7-dimethylocta-2,6-dienoxy]-2,6-dihydroxy-5-methylphenyl]-2-methylbutan-1-one; 2-acetyl-3,5-dihydroxy-1-geranoxy-6-methyl-4-(2-methyl) butyryl-benzene","Ingredient_formula": "C24H34O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C(=C(C(=C1O)C)OCC=C(C)CCC=C(C)C)C(=O)C)O","Ingredient_weight": "402.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14136;SMIT19036","TCMID_id": "26099","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315778","DrugBank_id": "NA"}